Bay Island Cell
Shenzhen, China
◆ Total Raised
$19.6M
◆ Stage
series-a
◆ Location
Shenzhen, China
◆ Founded
2020
◆ Team size
1-10
◆ Links
◆ About Bay Island Cell
Cell therapy biotech company developing non-gene-editing universal CAR-T platform founded by former Legend Biotech executive Fan Xiaohu.
◆ What sets it apart
Their non-gene-editing universal CAR-T platform avoids genetic modification, enabling lower-cost, off-the-shelf cell therapies without the regulatory and safety hurdles of gene-edited approaches.
◆ Sectors
◆ Business
Modeltransactional
Customerpharmaceutical companies, hospital networks, and healthcare providers seeking cost-effective CAR-T therapies
◆ Notable
- Raised RMB 140 million in funding to advance CAR-T cost reduction efforts
◆ Funding rounds
◆ Explore the market
◆ FAQ
What does Bay Island Cell do?
Cell therapy biotech company developing non-gene-editing universal CAR-T platform founded by former Legend Biotech executive Fan Xiaohu.
Where is Bay Island Cell based?
Bay Island Cell is based in Shenzhen, China, founded in 2020.
How much has Bay Island Cell raised?
Bay Island Cell has raised $19.6M in tracked funding and is currently at the series-a stage.
Who has invested in Bay Island Cell?
Investors in Bay Island Cell include null.